Novocure announced on Tuesday that the FDA treated its Optune Lua wearable device for treating metastatic non-small cell lung ...

The ROP procedure. [Image courtesy of AAO/FundamentalVR] The American Academy of Ophthalmology (AAO), in partnership with ...

HeartBeam (Nasdaq:BEAT) announced today that it appointed Robert Eno as its new CEO, effective Monday, Oct. 21, 2024.

The FDA today issued a notice classifying the recall of Cue Health COVID-19 tests as Class II and revoking the tests' EUA.